1. The use of ketogenic diets in cancer patients: a systematic review

   • Maximilian Römer
   • Jennifer Dörfler
   • Jutta Huebner

   Review Article Open access 03 April 2021 Pages: 501 - 536

   

2. Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes

   • Liu Liu
   • Menglu Jia
   • Zhongxing Jiang

   Review Article Open access 17 April 2021 Pages: 537 - 543

   

3. RAP2A promotes apoptosis resistance of hepatocellular carcinoma cells via the mTOR pathway

   • Jing-ru Yang
   • Xiao-ling Ling
   • Quan-lin Guan

   Original Article 20 May 2021 Pages: 545 - 554

   

4. Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?

   • Manuela Cabiati
   • Melania Gaggini
   • Silvia Del Ry

   Original Article 27 April 2021 Pages: 555 - 562

   

5. miR-1253, a novel tumor suppressor gene in colon cancer, is associated with poor patients prognosis

   • Daye Yang
   • Dewei Zhang

   Original Article 10 April 2021 Pages: 563 - 571

   

6. Different spatial distribution of inflammatory cells in the tumor microenvironment of ABC and GBC subgroups of diffuse large B cell lymphoma

   • Diego Guidolin
   • Roberto Tamma
   • Domenico Ribatti

   Original Article Open access 06 May 2021 Pages: 573 - 578

   

7. RETRACTED ARTICLE: Long non-coding RNA PICSAR serves as a non-invasive biomarker for the diagnosis and prognosis of cutaneous squamous cell carcinoma

   • Jianping Lv
   • Wei Zhang
   • Yanhua Wang

   Original Article 27 May 2021 Pages: 579 - 586

   

8. Inflammation response and liver stiffness: predictive model of regression of hepatic stiffness after sustained virological response in cirrhotics patients with chronic hepatitis C

   • Aline Márcia Marques Braz
   • Fernanda Cristina Winckler
   • Giovanni Faria Silva

   Original Article 09 April 2021 Pages: 587 - 597

   

9. Mesangial IgM deposition predicts renal outcome in patients with IgA nephropathy: a multicenter, observational study

   • Li Tan
   • Yi Tang
   • Wei Qin

   Original Article 10 April 2021 Pages: 599 - 610

   

10. The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity

    • Yanli Zeng
    • Yan Zhang
    • Yun Xiao

    Original Article 12 April 2021 Pages: 611 - 619

    

11. Expression profile of PU.1 in CD4⁺T cells from patients with systemic lupus erythematosus

    • Nan Xiang
    • Xuan Fang
    • Xiao-Mei Li

    Original Article 08 May 2021 Pages: 621 - 632

    

12. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness

    • Man Man Niu
    • Qi Jiang
    • Peng Hu

    Original Article 11 April 2021 Pages: 633 - 643

    

13. Single nucleotide polymorphisms of TRAF2 and TRAF5 gene in ankylosing spondylitis: a case–control study

    • Shanshan Xu
    • Jiangping Kong
    • Faming Pan

    Original Article 17 May 2021 Pages: 645 - 653

    

14. Altered peripheral helper T cells in peripheral blood and muscle tissue of the patients with dermatomyositis

    • Xiaoyu Hou
    • Chunshu Yang
    • Pingting Yang

    Original Article 26 April 2021 Pages: 655 - 661

    

15. The effects of streptokinase in a Chacma baboon (Papio ursinus) model of acquired thrombotic thrombocytopenic purpura

    • J. Joubert
    • S. M. Meiring
    • W. J. Janse van Rensburg

    Original Article 22 April 2021 Pages: 663 - 674

    

16. Circulating prostaglandin E₂: a novel potential prognostic biomarker in patients with hepatocellular carcinoma

    • Filippo Pelizzaro
    • Maria Piera Kitenge
    • Fabio Farinati

    Short Communication 25 March 2021 Pages: 675 - 682